Investing.com — Editas Medicine , Inc. (NASDAQ: EDIT )，一家基因编辑技术领导者，市值为1.14亿美元，宣布首席财务官Erick J. Lucera将于3月28日离开公司，寻求新的机会。现任财务高级副总裁Amy Parison将接任CFO职位。根据 InvestingPro ...

Editas Medicine (EDIT) announced CFO Erick Lucera is stepping down to pursue an external opportunity, effective March 28. Current senior VP of ...

Editas promoted Amy Parison, senior vice president of finance, to succeed Lucera as CFO, effective March 28. Parison, 39, will receive an annual base salary of $415,000 and will be eligible for an ...

Erick J. Lucera to Step Down as CFO to pursue another opportunitySenior Vice President of Finance Amy Parison Appointed CFOCAMBRIDGE, Mass., ...

Current Senior Vice President of Finance Amy Parison will succeed Mr. Lucera as Chief Financial Officer. “We are thrilled to promote Amy to the executive leadership team as our new CFO.